A mysterious company’s Covid-19 papers in top medical journals may be unraveling

Re:A mysterious company’s Covid-19 papers in top medical jou... by gamegod on Wednesday June 03, 2020 @04:47PM (#23408501)

As a reference, here's an observation study published in NEJM on May 7th, that wrote:

https://www.nejm.org/doi/full/10.1056/NEJMoa2012410?query=fe...

> "In this analysis involving a large sample of consecutive patients who had been hospitalized with Covid-19, the risk of intubation or death was not significantly higher or lower among patients who received hydroxychloroquine than among those who did not..."

Note that this study did not use any of the data from Mehra et. al. You see all the other studies that found similar results by reading the references.

[ Parent | on HN ]

Re:A mysterious company’s Covid-19 papers in top medical jou... by gator-io on Wednesday June 03, 2020 @05:48PM (#23409244)

I'm not arguing other studies - they seem fine, except none of them studied the early use of HCQ with Zinc.

I'm saying specifically that the Lancet should not have published the Surgisphere study due to its flaws.

[ Parent | on HN ]